Corient Private Wealth LLC Decreases Stake in UnitedHealth Group Incorporated $UNH

Corient Private Wealth LLC decreased its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 57.3% during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 476,973 shares of the healthcare conglomerate’s stock after selling 640,011 shares during the quarter. Corient Private Wealth LLC’s holdings in UnitedHealth Group were worth $148,801,000 as of its most recent filing with the SEC.

A number of other institutional investors also recently made changes to their positions in the business. LFA Lugano Financial Advisors SA bought a new stake in shares of UnitedHealth Group in the second quarter worth $25,000. Bayforest Capital Ltd raised its stake in shares of UnitedHealth Group by 685.7% in the 1st quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate’s stock valued at $29,000 after purchasing an additional 48 shares in the last quarter. Sagard Holdings Management Inc. acquired a new position in UnitedHealth Group in the second quarter worth about $29,000. Islay Capital Management LLC acquired a new stake in UnitedHealth Group during the second quarter valued at approximately $31,000. Finally, Riggs Asset Managment Co. Inc. raised its position in shares of UnitedHealth Group by 69.4% during the 2nd quarter. Riggs Asset Managment Co. Inc. now owns 105 shares of the healthcare conglomerate’s stock valued at $33,000 after acquiring an additional 43 shares in the last quarter. 87.86% of the stock is owned by institutional investors and hedge funds.

UnitedHealth Group Trading Up 1.5%

NYSE:UNH opened at $341.83 on Monday. UnitedHealth Group Incorporated has a 1 year low of $234.60 and a 1 year high of $606.36. The business has a fifty day moving average of $339.84 and a 200-day moving average of $317.20. The company has a debt-to-equity ratio of 0.71, a quick ratio of 0.82 and a current ratio of 0.82. The stock has a market cap of $309.65 billion, a price-to-earnings ratio of 17.84, a PEG ratio of 2.23 and a beta of 0.43.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, October 28th. The healthcare conglomerate reported $2.92 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.87 by $0.05. UnitedHealth Group had a net margin of 4.04% and a return on equity of 19.23%. The firm had revenue of $113.16 billion during the quarter, compared to analyst estimates of $113.19 billion. During the same quarter in the prior year, the firm posted $7.15 EPS. UnitedHealth Group’s revenue was up 12.2% compared to the same quarter last year. Equities analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Tuesday, December 16th. Shareholders of record on Monday, December 8th will be given a $2.21 dividend. This represents a $8.84 dividend on an annualized basis and a yield of 2.6%. The ex-dividend date is Monday, December 8th. UnitedHealth Group’s dividend payout ratio is 46.14%.

Analysts Set New Price Targets

A number of analysts have weighed in on UNH shares. Cantor Fitzgerald reissued an “overweight” rating and set a $440.00 target price on shares of UnitedHealth Group in a report on Tuesday, August 26th. Truist Financial raised their target price on shares of UnitedHealth Group from $310.00 to $365.00 and gave the stock a “buy” rating in a report on Tuesday, September 9th. JPMorgan Chase & Co. increased their price target on UnitedHealth Group from $310.00 to $425.00 and gave the stock an “overweight” rating in a research report on Thursday, October 9th. Morgan Stanley boosted their price objective on UnitedHealth Group from $325.00 to $395.00 and gave the company an “overweight” rating in a research report on Friday, September 12th. Finally, TD Cowen raised their target price on UnitedHealth Group from $335.00 to $338.00 and gave the company a “hold” rating in a research note on Thursday, October 30th. Seventeen investment analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and three have assigned a Sell rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus target price of $385.54.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.